Cargando…
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
Current evidence does not provide definitive answers regarding the benefits (or otherwise) of oxygen therapy for ILD http://ow.ly/4qr830dCYm4
Autores principales: | Bell, Emily C., Cox, Narelle S., Goh, Nicole, Glaspole, Ian, Westall, Glen P., Watson, Alice, Holland, Anne E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488502/ https://www.ncbi.nlm.nih.gov/pubmed/28794146 http://dx.doi.org/10.1183/16000617.0072-2017 |
Ejemplares similares
-
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
por: Schaeffer, Michele R., et al.
Publicado: (2017) -
Oxygen therapy for interstitial lung disease: a systematic review
por: Bell, Emily C., et al.
Publicado: (2017) -
The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021) -
Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020) -
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
por: Vicenzi, Marco, et al.
Publicado: (2020)